Skip to content

Preventive effect of transcutaneous acupoint electrical stimulation with different time duration on postoperative delirium in elderly patients with gastrointestinal tumors

Preventive effect of transcutaneous acupoint electrical stimulation with different time duration on postoperative delirium in elderly patients with gastrointestinal tumors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053709
Enrollment
Unknown
Registered
2021-11-27
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Experimental group1:TEAS will be applied on Neiguan and Hegu acupoints 30 minutes before anesthesia induction with dense waves, the maximum intensity that patients can tolerate until the anesthesia in
Experimental group2:TEAS will be applied on Neiguan and Hegu acupoints 30 minutes before anesthesia induction with dense waves, the maximum intensity that patients can tolerate until the end of surger
Experimental group3:TEAS will be applied on Neiguan and Hegu acupoints from anesthesia induction with dense waves, the maximum intensity that patients can tolerate until the end of surgery
Experimental group4:The electrode tablets will be placed on Neiguan and Hegu acupoints 30 minutes before anesthesia induction to the end of surgery without electrical stimulation

Sponsors

The First Hospital Affiliated with the Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who are scheduled to undergo abdominal gastrointestinal tumor surgery under general anesthesia; 2. Aged >= 65 years; 3. ASA I~II level.

Exclusion criteria

Exclusion criteria: 1. A history of dementia, delirium or neurological and psychiatric diseases caused by various etiologies; 2. Are using sedative or antidepressant drugs; 3. A history of alcohol or drug dependence; 4. History of endocrine or metabolic disorders or recent use of glucocorticoids or other hormones; 5. Patients who plan to be admitted to the ICU before surgery 6. Suffering from infection or chronic inflammation and using anti-inflammatory drugs; 7. There is trauma, rupture, infection, etc. in the site to be subjected to electrical stimulation; 8. Suffering from severe arrhythmia; 9. Unwilling or unable to cooperate (language impairment, severe hearing, visual impairment) to complete the experiment.

Design outcomes

Primary

MeasureTime frame
Updated Delirium Assessment Scale score;

Secondary

MeasureTime frame
Serum C-reactive protein concentration;Serum cholinesterase concentration;Serum total bilirubin concentration;

Countries

China

Contacts

Public ContactFang Bo

Department of Anesthesiology, the First Hospital Affiliated with the Chinese Medical University

bfang@cmu.edu.cn+86 13591652713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026